Noticias Lyra Therapeutics Inc - LYRA | Acciones NASDAQ | ADVFN

US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

Lyra Therapeutics Inc (LYRA)

0.18

0.01

(5.88%)

Cerrado 21 Diciembre 3:00PM

Delayed by 15 minutes

0.183

0.003

(1.67%)

Fuera de horario: 6:58PM

Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Lyra Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Company continues to focus on upcoming results from ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients expected...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN 2 Trial of LYR-210 for the Treatment of Chronic Rhinosinusitis

-- Topline Results Expected Q2 2025 -- WATERTOWN, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Lyra...

Lyra Therapeutics to Present Study Results for LYR-210 and LYR-220 in Two Presentations at the ARS and AAO-HNS Annual Meetings

WATERTOWN, Mass., Sept. 27, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), (“Lyra” or the...

Dennis14

Dennis14 4 meses hace

Dennis14

Dennis14 4 meses hace

Big buys after hours 86000 buy and (3)50000 buys

Dennis14

Dennis14 4 meses hace

It now says 13th after hours. We will see

Dennis14

Dennis14 4 meses hace

Earnings supposed to be on the 12th Aug.

Dennis14

Dennis14 5 meses hace

I just read. Earnings coming out next week or the week after.

Dennis14

Dennis14 5 meses hace

Earnings coming out any day now.

BigBadWolf

BigBadWolf 6 meses hace

DDAmanda finds them early so that Han's (he provided the name pumping testimonials) can sell off his early buys while he's pumping to his paid subscribers. Want proof DDAmanda $subscribers PM me for verification or simply check my posting history for the mud this P_G waddles in..
https://lyratherapeutics.com/

SantaZar

SantaZar 6 meses hace

Well, 6 weeks ago she was $5: $LYRA Chart from #DDAmanda - #1 Stock Screener :

Find Winners Early:

Z

Termite7

Termite7 6 meses hace

Who? .....How high for LYRA? .......Thanks!!!

SantaZar

SantaZar 6 meses hace

Nice list.........$LYRA is due.......according to #DDAmanda.

Z

Termite7

Termite7 6 meses hace

Oversold!!! ......https://finviz.com/screener.ashx?v=110&s=ta_oversold&o=change

SantaZar

SantaZar 7 meses hace

$LYRA Book Value is $1.27 ......trading at .34 ........or 1/4 the BV........

Z

INV4

INV4 7 meses hace

LYRA Institutional Holdings
Ownership Summary

Institutional Ownership • 74.73%
Total Shares Outstanding (millions) • 61
Total Value of Holdings (millions) • $16

Active Positions • Holders • Shares
Increased Positions • 54 • 9,224,767
Decreased Positions • 19 • 6,026,566
Held Positions • 11 • 30,304,888

Institutional Holders: 84
Total Shares Held: 45,556,221

$BLEG

LYRA Analyst Research
Lyra Therapeutics, Inc. Common Stock (LYRA) Analyst Research
LYRA Earnings Consensus

CONSENSUS
Buy
Based on 6 analysts offering recommendations for 'LYRA'.

Analyst Price Targets
CONSENSUS
$0.95

Based on analysts offering 12 month price targets for LYRA in the last 3 months.
The average price target is $0.95 with a high estimate of $2 and a low estimate of $0.35.

https://www.nasdaq.com/market-activity/stocks/lyra/analyst-research

$LYRA

SantaZar

SantaZar 7 meses hace

$LYRA Bounce anytime now...............

Z

INV4

INV4 7 meses hace

Let's see when it bounces 😀

$LYRA

glenn1919

glenn1919 7 meses hace

LYRA.........................................https://stockcharts.com/h-sc/ui?s=LYRA&p=W&b=5&g=0&id=p86431144783

SantaZar

SantaZar 7 meses hace

Yes. Expecting a nice $LYRA Bounce..............

Z

Dennis14

Dennis14 7 meses hace

Relative Strength Index is at 12 this is way over sold.

SantaZar

SantaZar 8 meses hace

$LYRA Book Value: $1.28 ....currently at .43 ...

Z

Dennis14

Dennis14 8 meses hace

Bought in this morning at .42, I believe this will be back to at least 1 or 2 bucks.

axelvento

axelvento 8 meses hace

game over: announced topline results from the Phase 3 ENLIGHTEN 1 trial evaluating LYR-210 for the treatment of chronic rhinosinusitis (CRS). ENLIGHTEN 1 did not meet its primary endpoint

Monksdream

Monksdream 8 meses hace

Monksdream

Monksdream 9 meses hace

TrendTrade2016

TrendTrade2016 9 meses hace

LYRA...NOT HOLDING INTO ER

TrendTrade2016

TrendTrade2016 9 meses hace

LYRA...LETS SEE 7.00

TrendTrade2016

TrendTrade2016 9 meses hace

LYRA...EXPLODING!!!!!

Monksdream

Monksdream 9 meses hace

LYRA 10Q due March 14

TrendTrade2016

TrendTrade2016 9 meses hace

LYRA...BEAUTIFUL BREAK OUT

TrendTrade2016

TrendTrade2016 9 meses hace

LYRA....BIO BEAST!

TrendTrade2016

TrendTrade2016 9 meses hace

LYRA...HERE WE GO

TrendTrade2016

TrendTrade2016 9 meses hace

LYRA...MOVES ON AIR!!!

TrendTrade2016

TrendTrade2016 9 meses hace

LYRA...HERE WE GO

Monksdream

Monksdream 10 meses hace

LYRA 10Q due March 7

TrendTrade2016

TrendTrade2016 10 meses hace

LYRA..WHAT A BEAUTY...NOBODY TALKING!!!

TrendTrade2016

TrendTrade2016 10 meses hace

LYRA...NEXT BIO BEAST READY TO BEAST

Monksdream

Monksdream 1 año hace

LYRA No 3 on the Barchart Top 10
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc

Lyra Therapeutics

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones